Is there a potential dual effect of denosumab for treatment of osteoporosis and sarcopenia?

Autor: Miedany YE; King's College London, London, UK.; Canterbury Christ Church University, Kent, England., Gaafary ME; Department of Community and Public Health, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Toth M; Darent Valley Hospital, Dartford, Kent, UK., Hegazi MO; Al Adan Hospital, Hadiya, Kuwait., Aroussy NE; Department of Rheumatology and Rehabilitation, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Hassan W; Department of Rheumatology and Rehabilitation, Benha University, Benha, Egypt., Almedany S; Department of Rheumatology and Rehabilitation, Tanta University, Tanta, Egypt., Nasr A; Department of Radiology, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Bahlas S; Department of Rheumatology, King Abdulaziz University, Jeddah, Saudi Arabia., Galal S; Department of Rheumatology and Rehabilitation, Faculty of Medicine, Ain Shams University, Cairo, Egypt. dr_salwa07@yahoo.com.

Publikováno v: Clinical rheumatology [Clin Rheumatol] 2021 Oct; Vol. 40 (10), pp. 4225-4232. Date of Electronic Publication: 2021 May 19.

Association of Paraoxonase 1 Polymorphism and Serum 25-Hydroxyvitamin D with the Risk of Cardiovascular Disease in Patients with Rheumatoid Arthritis.

Autor: Khoja SO, Miedany YE, Iyer AP, Bahlas SM, Balamash KS, Elshal MF

Publikováno v: Clinical laboratory [Clin Lab] 2017 Nov 01; Vol. 63 (11), pp. 1841-1849.

Treat to target for osteoporosis: another step forward.

Autor: Miedany YE; Darent Valley Hospital, Dartford, Kent, UK. drelmiedany@rheumatology4u.com.

Publikováno v: Current rheumatology reviews [Curr Rheumatol Rev] 2014; Vol. 10 (2), pp. 99-105.